Early Discontinuation of Levothyroxine Treatment Is Safe and Feasible in Extremely Low Birth Weight Infants with Delayed Hyperthyrotropinemia.

MLA

Kim, Ji Sook, et al. “Early Discontinuation of Levothyroxine Treatment Is Safe and Feasible in Extremely Low Birth Weight Infants with Delayed Hyperthyrotropinemia.” Neonatology (16617800), vol. 120, no. 1, Mar. 2023, pp. 33–39. EBSCOhost, https://doi.org/10.1159/000526701.

APA

Kim, J. S., Chang, Y. S., Ahn, S. Y., Sung, S. I., Yang, M. S., & Park, W. S. (2023). Early Discontinuation of Levothyroxine Treatment Is Safe and Feasible in Extremely Low Birth Weight Infants with Delayed Hyperthyrotropinemia. Neonatology (16617800), 120(1), 33–39. https://doi.org/10.1159/000526701

Chicago

Kim, Ji Sook, Yun Sil Chang, So Yoon Ahn, Se In Sung, Mi Sun Yang, and Won Soon Park. 2023. “Early Discontinuation of Levothyroxine Treatment Is Safe and Feasible in Extremely Low Birth Weight Infants with Delayed Hyperthyrotropinemia.” Neonatology (16617800) 120 (1): 33–39. doi:10.1159/000526701.